CIK 0001314102 · Non-accelerated filer<br>Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262774444
- Phone
- 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $52,258
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$52,258. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-03 | Elston George Chief Financial Officer | Option exercise | +19,667 | 76,781 | ||
| 2026-01-03 | Elston George Chief Financial Officer | Shares withheld for taxes | −6,324 | $17.48 | $111K | 70,457 |
| 2026-01-03 | Elston George Chief Financial Officer | Option exercise · Restricted Stock Units | −19,667 | 39,333 | ||
| 2026-01-02 | Sanders Reginald J. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-01-02 | Ribeiro Ramiro Chief Medical Officer | Grant or award · Restricted Stock Units | +85,700 | 85,700 | ||
| 2026-01-02 | Ribeiro Ramiro Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +171,400 | 171,400 | ||
| 2026-01-02 | Duty Stuart Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-01-02 | Duker Jay S. President and CEO | Grant or award · Restricted Stock Units | +165,000 | 165,000 | ||
| 2026-01-02 | Duker Jay S. President and CEO | Grant or award · Stock Option (Right to Buy) | +331,000 | 331,000 | ||
| 2026-01-02 | Zaderej Karen L. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-01-02 | Landis John B. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-01-02 | Lurker Nancy Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-01-02 | Elston George Chief Financial Officer | Grant or award · Restricted Stock Units | +63,000 | 63,000 | ||
| 2026-01-02 | Elston George Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +126,000 | 126,000 | ||
| 2026-01-02 | DICICCO WENDY F Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-01-02 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +41,500 | 41,500 | ||
| 2026-01-02 | Hassan Fred Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-12-19 | Elston George Chief Financial Officer | Gift | −5,000 | 57,114 | ||
| 2025-12-19 | Elston George Chief Financial Officer | Gift | +5,000 | 25,000 | ||
| 2025-12-04 | Cormorant Asset Management, LP Former 10% Owner | Sale | −60,000 | $15.70 | $942K | 8,265,000 |
Page 4 of 18 · 352 trades